1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Undifferentiated Fallopian Tube Carcinoma: new trials by email Literature Review of Undifferentiated Fallopian Tube Carcinoma trials Research Report on Undifferentiated Fallopian Tube Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Behavioral Dietary Intervention, Compliance Monitoring, Counseling - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Unknown | Gynecologic Oncology Group | 1070 | 2012-06-18 | 2018-02-19 |
| Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Bevacizumab, Carboplatin, Laboratory Biomarker Analysis - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1873 | 2005-09-01 | 2019-07-23 |
Brenner Tumor (2) · Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (1)
Adnexal Diseases (2) · Endocrine System Diseases (2) · Fallopian Tube Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Fibroepithelial (2)
Bevacizumab (1) · Carboplatin (1) · Counseling (1) · Disulfides (1) · Early Intervention, Educational (1) · Educational Status (1) · Immunoglobulin G (1) · Methods (1) · Paclitaxel (1) · Taxes (1)
Gynecologic Oncology Group (1) · National Cancer Institute (NCI) (1)
United States (2) · Canada (1) · Japan (1) · South Korea (1)
David Alberts (1) · Robert Burger (1)
PMID 21941283, PMID 22204724, PMID 23219660, PMID 26487588, PMID 27394382, PMID 29550184, PMID 31216226, PMID 35144591, PMID 36252167, PMID 36608382, PMID 37185961
U10CA027469 (1), U10CA101165 (1), U10CA180830 (1), U10CA180868 (1), UG1CA189867 (1)